Rosiglitazone (Avandia) Linked to Fractures in Women

The FDA and drug company advised clinicians to carefully consider fracture risk before initiating rosiglitazone therapy

the risk of fracture should be considered in the care of patients, especially female patients, with type 2 diabetes mellitus who are currently being treated with rosiglitazone, or when initiation of rosiglitazone treatment is being considered."